Abstract B047: Biochemical parameters of

prostate cancer patients in Nigeria by Iweala, E. E. J. et al.
Skip to main content 
 
Poster Presentations - Proffered Abstracts 
Abstract B047: Biochemical parameters of 
prostate cancer patients in Nigeria 
Emeka Iweala, Solomon Rotimi, Faith Kanu and Chidiebere Ogo 
DOI: 10.1158/1538-7445.PRCA2017-B047 Published August 2018 
 
Abstracts: AACR Special Conference: Prostate Cancer: Advances in Basic, Translational, and Clinical 
Research; December 2-5, 2017; Orlando, Florida 
Abstract 
The screening of biochemical parameters of cancer patients and their development into reliable and 
specific diagnostic and prognostic biomarkers has been reported in several studies. The biochemical 
signature of prostate cancer patients in Nigeria may vary from others and can serve as important 
leads in discovery of new biomarkers for the disease. This will ultimately provide more information 
on the specific causes and prognosis of the disease as well as improve its diagnosis and 
management. This study examined some biochemical parameters including alanine transaminase 
(ALT), alkaline phosphatase (ALP), low-density lipoprotein (LDL), high-density lipoprotein (HDL), 
triglycerides (TRIG), reduced glutathione (GSH), lipid peroxidation and peroxidase (POD) in the 
plasma of prostate cancer patients and controls. The data obtained indicate that there were no 
significant differences in the ALT, LDL, HDL, and POD while ALP and TRIG were significantly 
increased. Also, there was a significant reduction in GSH. This indicates the possible implication of 
ALP, TRIG, and GSH in prostate cancer disease in Nigeria and their potential to be further 
developed into diagnostic and prognostic biomarkers. 
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